Corient Private Wealth LLC Sells 17,624 Shares of Masimo Corporation $MASI

Corient Private Wealth LLC lowered its position in shares of Masimo Corporation (NASDAQ:MASI) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 330,414 shares of the medical equipment provider’s stock after selling 17,624 shares during the quarter. Corient Private Wealth LLC owned 0.61% of Masimo worth $55,582,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Nordea Investment Management AB lifted its position in Masimo by 21.6% during the 2nd quarter. Nordea Investment Management AB now owns 31,868 shares of the medical equipment provider’s stock worth $5,330,000 after buying an additional 5,659 shares in the last quarter. 4D Advisors LLC grew its holdings in shares of Masimo by 50.0% in the 2nd quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after acquiring an additional 15,000 shares in the last quarter. Westfield Capital Management Co. LP increased its position in shares of Masimo by 75.9% in the second quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock valued at $198,702,000 after acquiring an additional 509,724 shares during the last quarter. Strs Ohio bought a new stake in Masimo during the first quarter worth about $6,686,000. Finally, Swedbank AB bought a new stake in Masimo during the first quarter worth about $12,645,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Trading Down 2.1%

Shares of Masimo stock opened at $134.52 on Wednesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.84 and a quick ratio of 1.92. The business has a fifty day simple moving average of $144.78 and a two-hundred day simple moving average of $151.09. Masimo Corporation has a 1 year low of $132.90 and a 1 year high of $194.88. The company has a market capitalization of $7.23 billion, a price-to-earnings ratio of -12.76, a P/E/G ratio of 1.49 and a beta of 1.26.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share for the quarter. The company had revenue of $617.00 million for the quarter. Masimo had a negative net margin of 33.20% and a positive return on equity of 33.04%. Research analysts forecast that Masimo Corporation will post 4.1 EPS for the current year.

Analyst Upgrades and Downgrades

MASI has been the subject of a number of analyst reports. Wells Fargo & Company restated an “overweight” rating and issued a $190.00 price target on shares of Masimo in a research note on Friday, December 5th. Zacks Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. BTIG Research boosted their target price on shares of Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Wednesday, October 8th. Finally, Bank of America began coverage on shares of Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 price objective on the stock. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Masimo has an average rating of “Hold” and an average price target of $189.40.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.